Safety and efficacy of sucroferric oxyhydroxide in pediatric patients with chronic kidney disease

BACKGROUND: Pediatric patients with advanced chronic kidney disease (CKD) are often prescribed oral phosphate binders (PBs) for the management of hyperphosphatemia. However, available PBs have limitations, including unfavorable tolerability and safety. METHODS: This phase 3, multicenter, randomized,...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Pediatr Nephrol
Main Authors: Greenbaum, Larry A., Jeck, Nikola, Klaus, Günter, Fila, Marc, Stoica, Cristina, Fathallah-Shaykh, Sahar, Paredes, Ana, Wickman, Larysa, Nelson, Raoul, Swinford, Rita D., Abitbol, Carolyn Larkins, Balgradean, Mihaela, Jankauskiene, Augustina, Perrin, Amandine, Enoiu, Milica, Ahn, Sun-Young
Format: Artigo
Jezik:Inglês
Izdano: Springer Berlin Heidelberg 2020
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8009783/
https://ncbi.nlm.nih.gov/pubmed/33106892
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00467-020-04805-y
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki